Accessible

Doctors Without Borders, an esteemed international medical charity, is urgently appealing to major pharmaceutical companies and every manufacturer of insulin to dramatically improve access to diabetes treatments in low- and middle-income nations. They’re advocating for the availability of insulin pen injection devices at a price point of just $1. In their recent announcement, they underscored a staggering fact: approximately 80% of individuals living with diabetes are found in low- and middle-income countries. These regions…